AtaiBeckley

ATAINasdaq Germany Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.669 B

$7.25 +0.97%

Close of 7 Aug 2026

Revenue

$4.09M

#3339 by revenue

Earnings

-$660.0M

Loss-making

Shares outstanding

364,745,985

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#83ImmunomeIMNM$2.83B
#84Supernus PharmaceuticalsSUPN$2.77B
#85AtaiBeckleyATAI$2.67B
#86Nurix TherapeuticsNRIX$2.65B
#87Trevi TherapeuticsTRVI$2.63B

Where these numbers come from

Share counts and financials for AtaiBeckley are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.